Biomaterials Implant Articles & Analysis
9 news found
RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive ...
Healionics’ STARport HD, a novel preclinical stage implantable device that allows needle-free bloodstream access for hemodialysis treatment, has been selected by the American Society of Nephrology (ASN) to be featured at the ASN exhibit booth at Kidney Week 2016 as one of several new technologies portraying the future of kidney disease treatment. ...
” About Healionics Corporation Healionics develops and manufactures synthetic biomaterials and implantable medical devices that offer reduced foreign body reaction, fibrotic encapsulation and infection risk. The precisely controlled pore structure of Healionics’ innovative STAR® technology induces a favorable healing response and improves tissue ...
” About Healionics Corporation Healionics develops and manufactures STAR Biomaterials for implanted medical devices. The precisely controlled pore structure of the innovative STAR technology induces a favorable integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity. ...
About Healionics Corporation Healionics develops and manufactures STAR Biomaterials for implanted medical devices. The precisely controlled pore structure of the innovative STAR technology induces a favorable integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and ...
Titled, “Vascular Grafts for Needle Free Dialysis Access Devices,” the grant provides one-year funding to develop Healionics’ new STARgraft - a vascular graft based on STAR biomaterial that shows promise to reduce thrombosis and infection issues. ...
The STAR Biointerface is a textured porous tissue ingrowth layer that enhances the biocompatibility and infection resistance of implanted medical devices. The ingrowth layer can be formed by adhering granules of a porous biomaterial to a device surface. ...
This specification covers the raw material and final product requirements, and the associated test methods for the selection of porous high density and ultra high molecular weight polyethylenes intended for use in surgical implants. The porous polyethylene may be used as a free standing product or as a coating on a substrate in ...
This specification covers the chemical, mechanical, and metallurgical requirements for wrought titanium-15 molybdenum alloy to be used in the manufacture of surgical implants. The product shall be classified as: strip; ...